Inventor · disambiguated record
Kevin John Merchant
Also filed as: MERCHANT KEVIN · MERCHANT KEVIN J · MERCHANT KEVIN JOHN
31 granted patents·7 pending applications·834 citations·filing 1987–2021
97Inventor score
Files withMERCK SHARP & DOHME18TAKEDA PHARMACEUTICALS CO4FARNABY WILLIAM3MERCK SHARPE & DOHME LTD3TAKEDA PHARMACEUTICAL2
Top patents by PatentIndex Score
38 records- 0198US5514718AHeterocyclic compounds, processes for their preparation and pharmaceutical compositions containing themMERCK SHARP & DOHME·Filed 1994·Granted May 7, 1996·551 cites·12 claims
- 0288US6310203B1Precursor compounds to substituted 1,2,4-triazolo[3,4,-a]phathalazine GABA alpha 5 ligandsMERCK SHARPE & DOHME LTD·Filed 2000·Granted Oct 30, 2001·28 cites·2 claims
- 0384US11129828B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 28, 2021·1 cites·10 claims
- 0483US5472978AAromatic compounds, pharmaceutical compositions containing them and their use in therapyMERCK SHARP & DOHME·Filed 1992·Granted Dec 5, 1995·26 cites·9 claims
- 0582US5405853AThiadiazoles useful in the treatment of senile dementiaMERCK SHARPE & DOHME LTD·Filed 1993·Granted Apr 11, 1995·23 cites·8 claims
- 0680US9931340B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACUETICAL COMPANY LTD·Filed 2016·Granted Apr 3, 2018·4 cites·10 claims
- 0780US9290456B2Pyridazinone compounds and their use as DAAO inhibitorsFARNABY WILLIAM·Filed 2012·Granted Mar 22, 2016·4 cites·22 claims
- 0879US9180122B25- or 6-substituted 3-hydroxy-2 (1 H)-pyridinones as D-amino acid oxidase (DAAO) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and painFARNABY WILLIAM·Filed 2012·Granted Nov 10, 2015·6 cites·28 claims
- 0979US7279580B2Imidazo-pyridine derivatives as ligands for GABA receptorsMERCK SHARP & DOHME·Filed 2003·Granted Oct 9, 2007·15 cites·8 claims
- 1079US6200975B1Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as GABA alpha 5 ligandsMERCK SHARP & DOHME·Filed 1998·Granted Mar 13, 2001·42 cites·24 claims
- 1178US12186313B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2021·Granted Jan 7, 2025·0 cites·10 claims
- 1277US10463663B2Pyridazinone compounds and their use as DAAO inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Nov 5, 2019·1 cites·16 claims
- 1376US5973156APiperidine and tetrahydropyridine derivativesMERCK SHARP & DOME LTD·Filed 1996·Granted Oct 26, 1999·25 cites·12 claims
- 1472US7468393B2Diarylsulfones as 5-HT2A antagonistsMERCK SHARP & DOHME·Filed 2007·Granted Dec 23, 2008·1 cites·17 claims
- 1571US5519163AInhibitors of phosphoinositide-specific phospholipase CMERCK & CO INC·Filed 1993·Granted May 21, 1996·25 cites·6 claims
- 1670US7226926B28-fluoroimidazo 1,2-a pyridine derivatives as ligands for GABA receptorsMERCK SHARP & DOHME·Filed 2003·Granted Jun 5, 2007·5 cites·14 claims
- 1770US6444666B1Triazolopyridazine Derivatives for treating anxiety and enhancing cognitionMERCK SHARP & DOHME·Filed 1998·Granted Sep 3, 2002·15 cites·8 claims
- 1868US9750748B2Pyridazinones as DAAO enzyme inhibitorsTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Sep 5, 2017·1 cites·18 claims
- 1965US5612336AHeterocyclic amide derivatives as tachykinin antagonistsMERCK SHARP & DOHME·Filed 1993·Granted Mar 18, 1997·9 cites·13 claims
- 2065US5328927AHetercyclic compounds, processes for their preparation and pharmaceutical compositions containing themMERCK SHARPE & DOHME LTD·Filed 1993·Granted Jul 12, 1994·16 cites·13 claims
- 2164US5554627ATachykinin antagonistsMERCK SHARP & DOHME·Filed 1993·Granted Sep 10, 1996·8 cites·11 claims
- 2261US10085986B2Pyrimidinone compounds and their useCOCKCROFT XIAO LING FAN·Filed 2012·Granted Oct 2, 2018·1 cites·12 claims
- 2359US7452899B2Gamma-secretase inhibitorsMERCK SHARP & DOHME·Filed 2004·Granted Nov 18, 2008·1 cites·7 claims
- 2458US5686463AOxadiazoles useful in the treatment of senile dementiaMERCK SHARP & DOHME·Filed 1987·Granted Nov 11, 1997·8 cites·24 claims
- 2557US2013052281A1Novel compoundsFARNABY WILLIAM·Filed 2012·Application pending·0 cites
- 2656US7022724B2Cognition enhancing derivatives of isoxazole triazoloindane GABA-A α5 receptor subunit ligandsMERCK SHARP & DOHME·Filed 2002·Granted Apr 4, 2006·1 cites·7 claims
- 2755US2009170824A1Diarylsulfones as 5-HT2A AntagonistsCASTRO PINEIRO JOSE LUIS·Filed 2008·Application pending·0 cites
- 2850US2011124626A1Benzazepine derivatives and their use as histamine h3 antagonistsTAKEDA PHARMACEUTICAL·Filed 2009·Application pending·0 cites
- 2949US5811431ASpiro-substituted azacyclic derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 1995·Granted Sep 22, 1998·8 cites·25 claims
- 3046US6297235B1Triazolopyridazine derivatives for treating anxiety and enhancing cognitionMERCK SHARP & DOHME·Filed 1998·Granted Oct 2, 2001·6 cites·8 claims
- 3143US7592456B2Arylsulfonylnaphthalene derivatives as 5HT2A antagonistsMERCK SHARP & DOHME·Filed 2005·Granted Sep 22, 2009·0 cites·10 claims
- 3242US2009012134A1Arylsulfonyl Benzofused Heterocycles as 5-Ht2a AntagonistsCURTIS NEIL ROY·Filed 2006·Application pending·0 cites
- 3341US7060710B2Isoxazole pyrazoloindane derivatives as cognition enhancing GABAA α5 subtype ligandsMERCK SHARP & DOHME·Filed 2002·Granted Jun 13, 2006·0 cites·8 claims
- 3440US6448249B1Substituted 1,2,4-triazolo[3,4-A]phthalazine derivatives as GABAα5 ligandsMERCK SHARP & DOHME·Filed 1999·Granted Sep 10, 2002·1 cites·2 claims
- 3540US2008280956A1Heteroarylsulfonyl Stilbenes as 5-Ht2a AntagonistsGILLIGAN MYRA·Filed 2006·Application pending·0 cites
- 3638US2009209522A1Heterocyclic Non-Peptide GNRH AntagonistsSHOWELL GRAHAM ANDREW·Filed 2006·Application pending·0 cites
- 3736US5663352A4-phenyl-4-phenylpropyl(enyl)-piperidines as tachykinin antagonistsMERCK SHARP & DOHME·Filed 1994·Granted Sep 2, 1997·2 cites·19 claims
- 3833US2011172204A1Compounds and their useTAKEDA PHARMACEUTICAL·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →